• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[动脉硬化的二级预防]

[Secondary prevention of arteriosclerosis].

作者信息

Hoffmann U, Leu A J

机构信息

Abteilung Angiologie, Department für Innere Medizin, Universitätsspital Zürich.

出版信息

Praxis (Bern 1994). 1996 Sep 24;85(39):1201-5.

PMID:8927904
Abstract

Secondary prevention of arteriosclerosis tries to inhibit progression of the atherosclerotic process. Therapeutic measures focus on modification of cardiovascular risk factors and antithrombotic treatment. Hypercholesterolemia is the main risk factor for coronary artery disease. The risk of a coronary event is correlated to the plasma cholesterol level. Lowering plasma cholesterol results in reduction of vascular morbidity and mortality. Cigarette smoking is the predominant risk factor for peripheral arterial occlusive disease (PAOD). Smoking cessation reduces progression of PAOD and lowers cardiovascular morbidity and mortality. The preventive effect of antihypertensive therapy in hypertensive patients is most pronounced for cerebrovascular events. Antihypertensive measures improve prognosis after stroke and myocardial infarction. The increased cardiovascular risk in diabetics is in part explained by hyperglycemia and hyperinsulinemia, but also depends on coexisting dyslipidemia and hypertension. Intensive treatment of elevated blood glucose levels, dyslipidemia and hypertension are important preventive measures. Aspirin is highly effective in secondary prevention of vascular events. For the coronary arteries, low-dose aspirin is well established. Whether low-dose aspirin is equally effective for reducing progression of arteriosclerosis in the cerebrovascular and in the peripheral vessels is questionable. Ticlopidine serves as an alternative to aspirin; however, neutropenia may occur, which requires supervision of the patient.

摘要

动脉粥样硬化的二级预防旨在抑制动脉粥样硬化进程的发展。治疗措施主要集中在改善心血管危险因素和抗血栓治疗。高胆固醇血症是冠状动脉疾病的主要危险因素。冠状动脉事件的风险与血浆胆固醇水平相关。降低血浆胆固醇可降低血管疾病的发病率和死亡率。吸烟是外周动脉闭塞性疾病(PAOD)的主要危险因素。戒烟可减缓PAOD的发展,并降低心血管疾病的发病率和死亡率。抗高血压治疗对高血压患者预防脑血管事件的效果最为显著。抗高血压措施可改善中风和心肌梗死后的预后。糖尿病患者心血管疾病风险增加部分归因于高血糖和高胰岛素血症,但也取决于并存的血脂异常和高血压。强化治疗血糖升高、血脂异常和高血压是重要的预防措施。阿司匹林在血管事件的二级预防中非常有效。对于冠状动脉,小剂量阿司匹林已被广泛应用。小剂量阿司匹林在预防脑血管和外周血管动脉硬化进展方面是否同样有效尚存在疑问。噻氯匹定可作为阿司匹林的替代药物;然而,可能会出现中性粒细胞减少症,因此需要对患者进行监测。

相似文献

1
[Secondary prevention of arteriosclerosis].[动脉硬化的二级预防]
Praxis (Bern 1994). 1996 Sep 24;85(39):1201-5.
2
Update on aspirin in the treatment and prevention of cardiovascular disease.阿司匹林在心血管疾病治疗与预防中的最新进展。
Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700.
3
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.
4
Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.外周动脉疾病患者动脉粥样硬化血栓形成事件的药物预防
Eur J Clin Invest. 2007 Mar;37(3):157-64. doi: 10.1111/j.1365-2362.2007.01767.x.
5
Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].抗血小板治疗预防继发性中风和短暂性脑缺血发作:基层医疗医生的作用[已校正]
Int J Clin Pract. 2007 Oct;61(10):1739-48. doi: 10.1111/j.1742-1241.2007.01515.x.
6
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.氯吡格雷联合阿司匹林与单用阿司匹林用于二级预防及高危一级预防:氯吡格雷用于高动脉粥样硬化血栓形成风险和缺血性疾病的稳定、管理及预防(CHARISMA)试验的原理与设计
Am Heart J. 2004 Aug;148(2):263-8. doi: 10.1016/j.ahj.2004.03.028.
7
Secondary prevention of coronary artery disease.冠状动脉疾病的二级预防。
Am Fam Physician. 2010 Feb 1;81(3):289-96.
8
Classical risk factors and emerging elements in the risk profile for coronary artery disease.冠状动脉疾病风险概况中的经典危险因素和新出现的因素。
Eur Heart J. 1998 Feb;19 Suppl A:A53-61.
9
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.外周动脉疾病患者的最佳危险因素修正与药物治疗
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401.
10
[Pharmacologic interventions in primary prevention: lipid lowering drugs, aspirin, antiobesity drugs, and antihypertensive agents].[一级预防中的药物干预:降脂药物、阿司匹林、抗肥胖药物及抗高血压药物]
Wien Med Wochenschr. 2001;151(1-2):13-7.